[1] |
Parulski, C.; Jennotte, O.; Lechanteur, A.; Evrard, B. Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now? Adv. Drug Deliv. Rev. 2021, 175, 113810.
|
[2] |
Li, R.; Xu, X.Y.; Chen, D.; Zhang, Y.; Qian, H.N.; Zang, G.N.; Yan, G.R.; Li, R.; Fan, T.Y. Fused deposition modeling 3D printed oral famotidine pulsatile release tablets. J. Chin. Pharm. Sci. 2022, 31, 657–664.
|
[3] |
Zhao, Y.Y.; Wei, W.Q.; Niu, R.R.; Jiang, S.G. Research progress of fused deposition modelling in the field of oral solid preparations. J. Chin. Pharm. Sci. 2021, 56, 1291–1298.
|
[4] |
Muhindo, D.; Elkanayati, R.; Srinivasan, P.; Repka, M.A.; Ashour, E.A. Recent advances in the applications of additive manufacturing (3D printing) in drug delivery: a comprehensive review. AAPS PharmSciTech. 2023, 24, 1–22.
|
[5] |
Malebari, A.M.; Kara, A.; Khayyat, A.N.; Mohammad, K.A.; Serrano, D.R. Development of advanced 3D-printed solid dosage pediatric formulations for HIV treatment. Pharmaceuticals. 2022, 15, 435.
|
[6] |
van Kampen, E.E.M.; Ayyoubi, S.; Willemsteijn, L.; van Bommel, K.J.C.; Ruijgrok, E.J. The quest for child-friendly carrier materials used in the 3D semi-solid extrusion printing of medicines. Pharmaceutics. 2022, 15, 28.
|
[7] |
Chatzitaki, A.T.; Eleftheriadis, G.; Tsongas, K.; Tzetzis, D.; Spyros, A.; Vizirianakis, I.S.; Fatouros, D.G. Fabrication of 3D-printed octreotide acetate-loaded oral solid dosage forms by means of semi-solid extrusion printing. Int. J. Pharm. 2023, 632, 122569.
|
[8] |
Zhu, X.; Li, H.J.; Huang, L.F.; Zhang, M.; Fan, W.G.; Cui, L. 3D printing promotes the development of drugs. Biomed. Pharmacother. 2020, 131, 110644.
|
[9] |
Samiei, N. Recent trends on applications of 3D printing technology on the design and manufacture of pharmaceutical oral formulation: a mini review. Beni Suef Univ. J. Basic Appl. Sci. 2020, 9, 1–12.
|
[10] |
Zhang, H.; Li, S.F.; Si, Y.S.; Xu, H.W. Andrographolide and its derivatives: current achievements and future perspectives. Eur. J. Med. Chem. 2021, 224, 113710.
|
[11] |
Zhang, L.L.; Bao, M.; Liu, B.; Zhao, H.R.; Zhang, Y.; Ji, X.Y.; Zhao, N.; Zhang, C.; He, X.J.; Yi, J.F.; Tan, Y.; Li, L.; Lu, C. Effect of andrographolide and its analogs on bacterial infection: a review. Pharmacology. 2020, 105, 123–134.
|
[12] |
Gupta, S.; Mishra, K.P.; Ganju, L. Broad-spectrum antiviral properties of andrographolide. Arch. Virol. 2017, 162, 611–623.
|
[13] |
Kandanur, S.G.S.; Tamang, N.; Golakoti, N.R.; Nanduri, S. Andrographolide: a natural product template for the generation of structurally and biologically diverse diterpenes. Eur. J. Med. Chem. 2019, 176, 513–533.
|
[14] |
Burgos, R.A.; Alarcón, P.; Quiroga, J.; Manosalva, C.; Hancke, J. Andrographolide, an anti-inflammatory multitarget drug: all roads lead to cellular metabolism. Molecules. 2020, 26, 5.
|
[15] |
Kulsirirat, T.; Sathirakul, K.; Kamei, N.; Takeda-Morishita, M. The in vitro and in vivo study of novel formulation of andrographolide PLGA nanoparticle embedded into gelatin-based hydrogel to prolong delivery and extend residence time in joint. Int. J. Pharm. 2021, 602, 120618.
|
[16] |
Behrens, M.; Brockhoff, A.; Batram, C.; Kuhn, C.; Appendino, G.; Meyerhof, W. The human bitter taste receptor hTAS2R50 is activated by the two natural bitter terpenoids andrographolide and amarogentin. J. Agric. Food Chem. 2009, 57, 9860–9866.
|
[17] |
Narimanyan, M.; Jamalyan, K.; Balyan, A.; Barth, A.; Palm, S.; Wikman, G.; Panossian, A. Early intervention with Kan Jang® to treat upper-respiratory tract infections: a randomized, quadruple-blind study. J. Tradit. Complement. Med. 2021, 11, 552–562.
|
[18] |
Li, P.F.; Zhang, S.M.; Sun, W.L.; Cui, M.S.; Wen, H.Y.; Li, Q.J.; Pan, W.S.; Yang, X.G. Flexibility of 3D extruded printing for a novel controlled-release puerarin gastric floating tablet: design of internal structure. AAPS PharmSciTech. 2019, 20, 1–13.
|
[19] |
Sadia, M.; Arafat, B.; Ahmed, W.; Forbes, R.T.; Alhnan, M.A. Channelled Tablets: an innovative approach to accelerating drug release from 3D printed tablets. J. Control. Release. 2018, 269, 355–363.
|
[20] |
Indrati, O.; Martien, R.; Rohman, A.; Nugroho, A.K. Employment of atr-ftir and hplc-uv method for detection and quantification of andrographolide. Int. J. Appl. Pharm. 2018, 10, 135.
|
[21] |
Chinese Pharmacopoeia Commission. Pharmacopoeia of the people’s republic of China. Part IV. BeiJing: China Medical Science and Technology Press. 2020, 132.
|
[22] |
Geng, Z.J.; Ji, Y.X.; Yu, S.; Liu, Q.F.; Zhou, Z.B.; Guo, C.P.; Lu, D.H.; Pei, D.T. Preparation and characterization of a dual cross-linking injectable hydrogel based on sodium alginate and chitosan quaternary ammonium salt. Carbohydr. Res. 2021, 507, 108389.
|
[23] |
Han, L.; Yang, M.; Zhang, D.K.; Lin, J.Z.; Zhang, F.; Han, X.E.; Zou, W.Q. Preparation and evaluation of andrographolide solid dispersion vectored by silicon dioxide. Pharmacogn. Mag. 2016, 12, 245.
|
[24] |
Das, S.; Halder, A.; Mandal, S.; Abu Jafar Mazumder, M.; Bera, T.; Mukherjee, A.; Roy, P. Andrographolide engineered gold nanoparticle to overcome drug resistant visceral leishmaniasis. Artif. Cells Nanomed. Biotechnol. 2018, 46, 751–762.
|
[25] |
Liu, Q.Q.; Li, Q.T.; Xu, S.; Zheng, Q.J.; Cao, X.D. Preparation and properties of 3D printed Alginate–Chitosan polyion complex hydrogels for tissue engineering. Polymers. 2018, 10, 664.
|
[26] |
Banerjee, M.; Parai, D.; Chattopadhyay, S.; Mukherjee, S.K. Andrographolide: antibacterial activity against common bacteria of human health concern and possible mechanism of action. Folia Microbiol. 2017, 62, 237–244.
|